|
Market Closed -
Borsa Italiana
11:45:00 2026-10-02 am EDT
|
5-day change | 1st Jan Change | ||
| 1.075 EUR | -2.27% |
|
-3.15% | -26.87% |
| Sep. 27 | Laboratorio Farmaceutico Erfo S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Aug. 31 | Milan in the pink at the open, oil stocks lead the MIB | AN |
Company Valuation: Laboratorio Farmaceutico Erfo S.p.A.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Market Cap 1 | 18.27 | 11.79 | 10.8 | 12.53 |
| Change | - | -35.47% | -8.4% | 16.03% |
| Enterprise Value (EV) 1 | 17.38 | 11.41 | 10.81 | 12.83 |
| Change | - | -34.34% | -5.31% | 18.7% |
| P/E | 25.5x | 19.1x | 30.8x | 17x |
| PBR | 2.33x | 1.43x | 1.44x | 1.57x |
| PEG | -0.3x | -1.4x | -0.8x | 0x |
| Capitalization / Revenue | 3.87x | 1.99x | 1.79x | 1.29x |
| EV / Revenue | 3.68x | 1.92x | 1.79x | 1.32x |
| EV / EBITDA | 11.8x | 8.02x | 10.1x | 7x |
| EV / EBIT | 17.6x | 13.6x | 20.6x | 12x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Dividend per Share 2 | - | 0.06 | - | - |
| Rate of return | - | 4.58% | - | - |
| EPS 2 | 0.0796 | 0.0686 | 0.0411 | 0.0865 |
| Distribution rate | - | 87.4% | - | - |
| Net sales 1 | 4.719 | 5.932 | 6.032 | 9.732 |
| EBITDA 1 | 1.474 | 1.423 | 1.065 | 1.832 |
| EBIT 1 | 0.987 | 0.8367 | 0.5239 | 1.066 |
| Net income 1 | 0.7161 | 0.5903 | 0.3528 | 0.737 |
| Net Debt 1 | -0.8895 | -0.3784 | 0.005767 | 0.2954 |
| Reference price 2 | 2.030 | 1.310 | 1.265 | 1.470 |
| Nbr of stocks (in thousands) | 9,000 | 9,000 | 8,537 | 8,524 |
| Announcement Date | 4/12/23 | 5/8/24 | 4/14/25 | 4/12/26 |
1EUR in Million2EUR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 10.55M | |
| 32.69x | 11.85x | 24.08x | 0.6% | 1,025B | |
| 28.77x | 6.4x | 17.91x | 2.06% | 623B | |
| 32.89x | 7.71x | 15.93x | 2.67% | 459B | |
| 104.62x | 5.85x | 24.82x | 2.37% | 355B | |
| 18.99x | 4.63x | 11.47x | 2.87% | 336B | |
| 20.13x | 5.23x | 12.95x | 3.06% | 270B | |
| 20.27x | 4.21x | 12x | 2.1% | 247B | |
| 25.72x | 6.72x | 11.97x | 2.48% | 220B | |
| -44.61x | 6.5x | 25.4x | 2.23% | 183B | |
| Average | 26.61x | 6.57x | 17.39x | 2.27% | 371.82B | |
| Weighted average by Cap. | 31.73x | 7.64x | 18.71x | 1.95% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ERFO Stock
- Valuation Laboratorio Farmaceutico Erfo S.p.A.
Select your edition
All financial news and data tailored to specific country editions
